A multicenter phase II study of docetaxel (D) and carboplatin (CBDCA) combination in advanced non-small cell lung cancer (NSCLC). A preliminary analysis.

被引：0
|
作者：
Giannakakis, T [1 ]
Kakolyris, S [1 ]
Papadouris, S [1 ]
Mavroudis, D [1 ]
Kalbakis, K [1 ]
Souglakos, J [1 ]
Agelaki, S [1 ]
Passam, F [1 ]
Mixaki, J [1 ]
Georgoulias, V [1 ]
机构：
[1] Greek Cooperat Grp Lung Canc, Heraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
547P
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [1] Phase II study of Docetaxel (D) and Carboplatin (C) combination in advanced Non-Small Cell Lung Cancer (NSCLC)
    Chowdhury, Qamruzzaman
    Begum, Ferdous A.
    Nahar, Ferdous
    Fairuz, Saima
    Faruqui, Mesba
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S673 - S673
  • [2] Combination chemotherapy with carboplatin(CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Batzios, S
    Karvounis, N
    Athanassiou, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S263
  • [3] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Phase I/II trial of docetaxel (D) and Carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Giannakakis, T
    Papadouris, S
    Kourousis, C
    Kalbakis, NK
    Tzianni, V
    Lidaki, E
    Androulakis, N
    Souklakos, J
    Sarra, E
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [5] A phase II trial of concurrent radiochemotherapy with carboplatin (CBDCA) and weekly docetaxel (TXT) in locally advanced non-small cell lung cancer (NSCLC).
    Suzuki, R
    Taniguchi, H
    Kondoh, Y
    Shindoh, J
    Matsumoto, S
    Hiramatsu, T
    Gonda, H
    Baba, K
    Hasegawa, Y
    Shimokata, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 659S - 659S
  • [6] Phase I study of gemcitabine (GEM) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC).
    Kawabata, S
    Oka, M
    Fukuda, M
    Kinoshita, A
    Fukuda, M
    Nagashima, S
    Nakamura, Y
    Nakano, H
    Soda, H
    Kohno, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 688S - 688S
  • [7] Phase II study of combination of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Mitsuoka, Shigeki
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Yoshimura, Naruo
    Hirata, Kazuto
    ANNALS OF ONCOLOGY, 2006, 17 : 227 - 227
  • [8] A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer
    Giannakakis, T
    Kakolyris, S
    Theodoropoulos, E
    Kouroussis, C
    Michailakis, E
    Papadouris, S
    Tsitoura, M
    Kalbakis, K
    Souglakos, J
    Agelaki, S
    Vardakis, N
    Georgoulias, V
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3743 - 3748
  • [9] Phase II study of bevacizumab in combination with docetaxel and carboplatin in patients with metastatic non-small cell lung cancer (NSCLC)
    William, W. N., Jr.
    Kies, M. S.
    Fossella, F. V.
    Gladish, G.
    Heymach, J. V.
    Glisson, B. S.
    Tse, W. H.
    Liu, D.
    Herbst, R. S.
    Lippman, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] A phase II study of carboplatin and weekly docetaxel in advanced non-small cell lung cancer
    Moore, T
    Patel, T
    Segal, M
    Thompson, J
    Zangmeister, J
    Larrimer, N
    Merriman, N
    Chidiac, T
    LUNG CANCER, 2005, 49 : S259 - S259
12345